European Companies Search Engine
Capital: €11.4M · Company statute Hrb5 Mar 2010 German Trade Register Announcements, Germany (26/02/2010)
Overview
Text
STRATEC Biomedical Systems AG, Birkenfeld, Gewerbestr. 37, 75217 Birkenfeld. As a result of the conditional increase in the share capital (Conditional Capital II) decided on May 28, 2003, subscription shares with a par value of EUR 8,342.00 were issued between May 27, 2009 and November 11 and 2009; due to the conditional increase in the share capital (Conditional Capital III) decided on June 23, 2006, subscription shares with a par value of EUR 11,700.00 were issued between May 27, 2009 and November 11, 2009. The share capital is thus increased by EUR 20,042.00. On February 11, 2010, the Supervisory Board approved the amendment of the Articles of Association to Section 4 (share capital). Share capital now: EUR 11,445,736.00. The remaining amount of the conditional capital (Conditional Capital II) decided on May 28, 2003 is still EUR 46,210.00 after partial exploitation. The balance of the conditional capital (Conditional Capital III) decided on June 23, 2006 is still EUR 23,300.00 after partial exploitation.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: STRATEC SE, Birkenfeld, Germany.
The visualizations for "STRATEC Biomedical Systems AG - Capital: €11.4M · Company statute"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
